A major consequence of obesity is hyperinsulinemia, which drives both systemic and local production of IGF-1 and IGF-2 and increases IGF bioavailability by suppressing IGFBP expression [74]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.